Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Development of VP-50406 discontinued for treatment of hepatitis C

Nov. 15, 2001

Phase Ib laboratory analysis complete of Helivax vaccine against H. pylori

Nov. 15, 2001

Motilin antagonists identified at Ortho-McNeil

Nov. 12, 2001

Second Oxxon pharmaccine enters clinical testing

Nov. 8, 2001

CTD's orBec enters phase II for treatment of Crohn's disease

Nov. 8, 2001

Second Phase I grant awarded to Metabasis for liver disease research

Nov. 7, 2001

Gastric prokinetic agents with a hydroxyethoxybenzamide structure synthesized at Kissei

Nov. 6, 2001

Maxim to conduct phase II trial of Ceplene in triple combination therapy for hepatitis C

Nov. 5, 2001

Zelmac receives Swiss approval for treatment of IBS

Oct. 31, 2001

Carboxamide-based HCV NS3 protease inhibitors disclosed by DuPont

Oct. 30, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...